As biopharma doubles down on external innovation sourcing, community blood centres have become a surprising yet essential partner. Long recognised as the backbone of transfusion medicine, these ...

For the first time in coastal Karnataka at the corporate level, Yenepoya Speciality Hospital, Kodialbail, in association with ...

They’re small, sneaky and swimming in your veins. Microplastics have been found throughout the human body — and early research suggests they may pose some serious health risks. Now, scientists say a ...

This growing patient pool creates a direct and sustained demand for apheresis procedures, and consequently, for the equipment and disposables required to perform them. Second, the market is being ...

Introduction: Autologous peripheral blood stem cell (PBSC) transplantation has become a standard treatment option for certain hematological malignancies. The collection of PBSCs for transplantation is ...

A medical professional compares two blood samples/Getty Images For HDFN-affected pregnancies, intravenous immunoglobulin (IVIG) and plasmapheresis may be recommended to delay or prevent fetal anemia.

Introduction: Pre-apheresis peripheral blood CD34+ cell count (PBCD34+) is the most important predictor of good cell mobilization before hematopoietic stem cell transplantation, albeit flow cytometry ...

According to forecasts, the therapeutic apheresis industry is expected to be US$ 2,717.9 million in 2023 and US$ 5,264.4 million by 2033, the demand for therapeutic apheresis is estimated to rise at a ...

The recent blood shortage in the U.S.—exacerbated by the COVID-19 pandemic and a plummeting number of donations—has had a particularly strong effect on the growing demand for platelets, which help ...

During the projection period, it is predicted that demand for therapeutic apheresis would increase at a CAGR of 6.8%. The Therapeutic Apheresis Market share is anticipated to be worth US$ 2577.9 ...